Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn moreSpecies
Common marmosets are a small-bodied New World primate model of growing importance in neuroscience, drug safety, reproductive, and infectious-disease research. Alpha Genesis supports GLP and non-GLP studies and qualified animal supply under AAALAC-accredited, USDA-licensed facility standards, serving North American and global development programs.
Callithrix jacchus has become an increasingly important nonhuman primate model, valued for its small body size, rapid reproduction, and distinct neuroanatomical and physiological features. The small body size reduces test-article requirements, an advantage for early programs and costly biologics, while the species supports established use in neuroscience, drug safety and toxicology, reproductive and developmental biology, infectious disease, immunology, and aging research.
Alpha Genesis applies decades of NHP experience, spanning Old World and New World species, to its marmoset program, with the veterinary depth, behavioral management, and species-specific enrichment these small, cognitively complex primates require, because excellent welfare is fundamental to excellent science. Animals are cared for by primate specialists who pair social housing and enrichment with structured health monitoring, care that protects both animal wellbeing and the integrity of study data. Operations are AAALAC accredited, USDA registered, OLAW assured, and supported by IACUC oversight and experienced veterinary care, with study documentation consistent with internationally recognized GLP expectations.
Common marmoset study support and supply are available for research clients, with scope and cohort specifications confirmed during protocol review. Worldwide shipping and cross-border supply support are available for multinational sponsors, and all supply and logistics are conducted with full veterinary, regulatory, transportation, import/export, permitting, and animal-welfare documentation.
Common marmosets are used across research missions where a small, tractable New World primate provides scientific value. We support the following segments.
Sponsors requiring a small NHP model for drug safety and toxicology, PK/PD, or reproductive endpoints, where reduced test-article requirements and regulatory precedent for the species are advantageous, supporting North American and global development programs.
Academic and government investigators studying neural circuits, behavior, and neurological disease in a New World primate model with distinct neuroanatomical characteristics and growing genetic-model availability.
Grant-funded and institutional programs in infectious disease, immunology, reproductive biology, and aging requiring marmoset access, veterinary oversight, and documented health status.
Contract research organizations seeking marmoset access, in-life study support, or biospecimen collection to complement their own program offerings.
Common marmosets support research applications where their small size, tractability, and distinct biology provide scientific value in ways other NHP species do not.
Program engagement can be structured around study execution, animal supply, or combined services. Scope, timeline, and feasibility are confirmed during protocol review.
Full in-life study support from animal assignment through in-life procedures, data collection, necropsy, and sample delivery. GLP and non-GLP options available for qualified protocols.
Supply of health-screened common marmosets meeting sponsor specifications. Worldwide shipping and cross-border supply support are available for multinational sponsors, and all deliveries are conducted with full veterinary, regulatory, transportation, and import/export documentation.
Biospecimen collection from study or colony animals, client-owned colony boarding, and long-term colony support for sustained research programs.
Reliable preclinical data require more than protocol adherence, they require a facility culture built on SOP-driven veterinary medicine, behavioral welfare, and sponsor audit readiness.
Compliance is expected; how animals are cared for is what differentiates a primate program. Decades of veterinary and behavioral expertise make welfare a driver of data quality in our marmoset program, with formal accreditation and oversight providing the backing.
A small New World primate program in which reduced body size lowers test-article requirements, an advantage for early programs and costly biologics, supported by decades of primate husbandry experience and continuous veterinary oversight.
GLP and non-GLP study designs are available for research clients, supporting programs from early investigation through IND-enabling stages within a single, experienced facility, with documentation consistent with internationally recognized GLP expectations to support global development programs.
On-site veterinary staff with primate expertise provide clinical oversight, protocol review input, procedure execution, and welfare assurance throughout study conduct.
AAALAC-accredited, USDA-licensed, and OLAW-assured operations with sponsor audit readiness, structured documentation, and SOP-driven processes across all study phases.
The ability to supply animals and conduct in-life studies within the same organization reduces logistical handoffs, supports timeline predictability, and preserves data integrity.
Program managers, study directors, and primate technicians with experience across neuroscience, drug safety, reproductive, and infectious-disease research provide scientific and operational continuity.
Common marmoset supply is available for research clients. We support cohort requirements including cross-border supply for multinational sponsors, with worldwide shipping arranged as needed. All supply is conducted with full veterinary, regulatory, transportation, import/export, permitting, and animal-welfare documentation. Contact us to confirm cohort specifications and timeline.
Our team is available to review your protocol objectives, discuss animal availability, and assess program fit for neuroscience, drug safety, reproductive, and infectious-disease research in a small New World primate model.
